Osteoporosis : best practice & research compendium
Cyrus Cooper, Anthony D. Woolf
Abstract
Cyrus Cooper, Anthony D. Woolf
Abstract
Contents: Epidemiology of osteoporosis Fractures in the elderly: epidemiology and demography Pathogenesis of osteoporosis Prenatal and childhood influences on osteoporosis Corticosteroid osteoporosis Lower peak bone mass and its decline The role of bone turnover markers and risk factors in the assessment of osteoporosis and fracture risk The use of bone densitometry in clinical practice Role of biochemical markers in the management of osteoporosis Glucocorticoid-induced osteoporosis Osteoporosis in men Osteoporosis in childhood diseases: prevention and therapy Post-menopausal osteoporosis How to prevent fractures in the individual with osteoporosis Non-pharmacological interventions Phyto-oestrogens Oestrogen and selective receptor modulators (SERMS): current roles in the prevention and treatment of osteoporosis Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis Biologic therapies in osteoporosis Anabolic bone binding treatment [PTH] analogues and strontium Cost utility of treatment of osteoporosis Risk assessment in osteoporosis Future methods in the assessment of bone mass and structure
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Contents: Epidemiology of osteoporosis Fractures in the elderly: epidemiology and demography Pathogenesis of osteoporosis Prenatal and childhood influences on osteoporosis Corticosteroid osteoporosis Lower peak bone mass and its decline The role of bone turnover markers and risk factors in the assessment of osteoporosis and fracture risk The use of bone densitometry in clinical practice Role of biochemical markers in the management of osteoporosis Glucocorticoid-induced osteoporosis Osteoporosis in men Osteoporosis in childhood diseases: prevention and therapy Post-menopausal osteoporosis How to prevent fractures in the individual with osteoporosis Non-pharmacological interventions Phyto-oestrogens Oestrogen and selective receptor modulators (SERMS): current roles in the prevention and treatment of osteoporosis Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis Biologic therapies in osteoporosis Anabolic bone binding treatment [PTH] analogues and strontium Cost utility of treatment of osteoporosis Risk assessment in osteoporosis Future methods in the assessment of bone mass and structure
Key concepts: Osteoporosis, Medicine, Internal medicine, Calcitonin, Endocrinology